Meridian Co., Ltd. (MRDAF: OTC Pink No Information) | The company is cooperating with Stanford Medicia X aiming to international health care initiatives.

OTC

The company is cooperating with Stanford Medicia X aiming to international health care initiatives.

Dec 06, 2016

OTC Disclosure News Service

Gyeonggi-Do, Korea, Republic Of

The company is cooperating
with Stanford Medicia X aiming to international health care initiatives.

 

The company has been actively involved in “Pipeleine
Discovery Project” orchestrated by Standford Mecicine X, globally influencing
and funded medicine and medical research and development unit of Standford
Uniersity, and as a result, the company is going to have a major distribution contract
with Japanese counterparts both in private and public sector in near future. The
company and Standford Medicine X will continue to get invoved in the global
Health care Innovation projects and specifically in U.N.–led
international public health agenda.

Copyright © 2016 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply